Literature DB >> 30852937

Vancomycin Area Under the Curve Dosing and Monitoring at an Academic Medical Center: Transition Strategies and Lessons Learned.

Eric R Gregory1, Donna R Burgess2,3, Sarah E Cotner2,3, Jeremy D VanHoose2, Alexander H Flannery2,3, Brian Gardner2,3, Elizabeth B Autry2,3, Derek W Forster4, David S Burgess3, Katie L Wallace2,3.   

Abstract

Due to the inconsistent correlation of vancomycin trough concentrations with 24-hour area under the curve (AUC) and a desire to reduce rates of vancomycin-associated acute kidney injury, an institutional guideline was implemented by the Antimicrobial Stewardship Team in September 2017 to monitor vancomycin using AUC. Three stages were utilized to organize the process: preparation, implementation, and evaluation. The preparation stage was used to present literature to key stakeholders, and pharmacy meetings focused on the development of a dosing and monitoring guideline. Along with institution-wide education, the implementation stage included information technology development and support. The evaluation stage was comprised of quality improvement and clinical research. Future plans include dissemination of the results and analyses. Numerous lessons were learned due to barriers experienced during the process, but the transition was successful.

Entities:  

Keywords:  acute kidney injury; area under the curve; therapeutic drug monitoring; vancomycin

Mesh:

Substances:

Year:  2019        PMID: 30852937     DOI: 10.1177/0897190019834369

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  6 in total

1.  Should Therapeutic Monitoring of Vancomycin Based on Area under the Curve Become Standard Practice for Patients with Confirmed or Suspected Methicillin-Resistant Staphylococcus aureus Infection?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2020-06-01

2.  Gap Analysis for the Conversion to Area Under the Curve Vancomycin Monitoring in a Small Rural Hospital.

Authors:  Jennifer L Cole
Journal:  Fed Pract       Date:  2020-06

3.  Acute Kidney Injury Associated with Area under the Curve versus Trough Monitoring of Vancomycin in Obese Patients.

Authors:  Heather D'Amico; Katie L Wallace; Donna Burgess; David S Burgess; Sarah Cotner; Ryan Mynatt; Nannan Li; Arnold Stromberg; Jeremy VanHoose
Journal:  Antimicrob Agents Chemother       Date:  2021-10-11       Impact factor: 5.938

4.  Methods of Therapeutic Drug Monitoring to Guide Vancomycin Dosing Regimens: Trough Concentration versus Ratio of Area Under the Curve to Minimum Inhibitory Concentration.

Authors:  Ariane Du Sault; Marc Parent; Chantale Simard
Journal:  Can J Hosp Pharm       Date:  2022-04-04

5.  Therapeutic Drug Monitoring of Vancomycin in Adult Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia or Pneumonia.

Authors:  Ryan Marko; Julia Hajjar; Vanessa Nzeribe; Michelle Pittman; Vincent Deslandes; Nadia Sant; Juthaporn Cowan; Kwadwo Kyermentang; Tim Ramsay; Sheryl Zelenitsky; Salmaan Kanji
Journal:  Can J Hosp Pharm       Date:  2021

6.  Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study.

Authors:  Erin F Barreto; Andrew D Rule; Mohammad H Alshaer; Jason A Roberts; Mohd Hafiz Abdul Aziz; Marc H Scheetz; Kristin C Mara; Paul J Jannetto; Ognjen Gajic; John C O'Horo; Kasey R Boehmer
Journal:  Implement Sci Commun       Date:  2021-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.